A citation-based method for searching scientific literature

Juris J Meier, Julio Rosenstock, Agnès Hincelin-Méry, Christine Roy-Duval, Astrid Delfolie, Hans-Veit Coester, Bjoern A Menge, Thomas Forst, Christoph Kapitza. Diabetes Care 2015
Times Cited: 160



Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J Hoogwerf, Leigh MacConell, Bruce H R Wolffenbuttel. Diabetes Care 2014
Times Cited: 146




List of shared articles



Times cited

GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Juris J Meier. Mol Metab 2021
24




Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes.
Leigh Perreault, Helena Rodbard, Virginia Valentine, Eric Johnson. Adv Ther 2019
6

Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Guillermo E Umpierrez, Timothy S Bailey, Danielle Carcia, Charles Shaefer, Jay H Shubrook, Neil Skolnik. J Diabetes 2018
8

Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin.
Eric L Johnson, Juan P Frias, Jennifer M Trujillo. Postgrad Med 2018
6

The application of simple metrics in the assessment of glycaemic variability.
L Monnier, C Colette, D R Owens. Diabetes Metab 2018
36

The role of basal insulin and GLP-1 receptor agonist combination products in the management of type 2 diabetes.
Taylor R Inman, Erika Plyushko, Nicholas P Austin, Jeremy L Johnson. Ther Adv Endocrinol Metab 2018
4





Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano. Diabetes Care 2017
55